文献速递睡眠呼吸障碍

失眠作为舌下神经刺激参数与治疗成功的临床预测因素

Insomnia as a Clinical Predictor of Hypoglossal Nerve Stimulation Settings and Treatment Success.
PubMed 文献 · Laryngoscope · 2026-04-30

本研究回顾性分析80例接受舌下神经刺激(HNS)的成人OSA患者,35.5%术前合并失眠(COMISA,ISI≥15)。COMISA患者治疗所需刺激电压更低(1.5V vs 1.9V,p<0.01),达到Sher15成功标准比例更低(33.3% vs 62.0%,p=0.02),更多处于黄色路径2型(60.0% vs 32.0%,p=0.02)。

要点

  • COMISA患者HNS治疗所需刺激电压更低(1.5V vs 1.9V)。
  • COMISA患者达到Sher15成功标准的比例更低(33.3% vs 62.0%)。
  • COMISA患者更多处于黄色路径2型(依从性好但Sher15无应答)。

核心结论

  • COMISA患者HNS治疗刺激电压更低、刺激水平变化更少,达到Sher15成功标准的比例更低。
  • 需在刺激上调期间管理期望,平衡植入刺激耐受性与有效性以优化HNS结局。

研究设计与样本

  • 回顾性病历审查,纳入80例接受HNS手术的成人OSA患者。
  • 收集人口学信息、基线失眠严重指数(ISI)、植入前后睡眠研究及HNS刺激数据。
  • HNS治疗成功定义为AHI降低≥50%且AHI≤15(Sher15标准),并基于AHI症状和依从性按HNS治疗路径分类。

主要发现

  • 35.5%(n=30)患者术前基于ISI≥15诊断为COMISA。
  • COMISA患者治疗HNS刺激电压为1.5V,非COMISA为1.9V(p<0.01)。
  • COMISA患者平均HNS刺激水平较基线变化为0.8V,非COMISA为1.01V(p<0.05)。
  • COMISA患者达到Sher15标准比例为33.3%(n=10),非COMISA为62.0%(n=31)(p=0.02)。
  • COMISA患者60.0%(n=18)处于黄色路径2型,非COMISA为32.0%(n=16)(p=0.02),其他路径无显著差异。

关键数值与推荐

  • COMISA定义:术前ISI评分≥15。
  • HNS治疗成功标准(Sher15):AHI降低≥50%且AHI≤15。
  • 治疗路径分类基于AHI症状和依从性。

临床怎么用

  • 对COMISA患者进行HNS刺激上调时需管理期望,注意其可能需更低刺激电压且Sher15应答率较低。
  • 需平衡植入刺激耐受性与有效性以优化HNS治疗结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the impact of comorbid insomnia and obstructive sleep apnea (COMISA) on hypoglossal nerve stimulation (HNS) stimulation levels and rates of therapeutic success. METHODS: A retrospective chart review included adult OSA patients who received HNS surgery. Demographic information, baseline Insomnia Severity Index (ISI), pre and post implant sleep studies, and HNS stimulation data were collected. HNS therapy success was evaluated as ≥ 50% AHI reduction and AHI ≤ 15 (Sher15 criteria) and based on HNS treatment pathways using AHI symptoms and adherence. RESULTS: The cohort included 80 OSA patients treated with HNS therapy including 35.5% (n = 30) with pre-surgery COMISA based on ISI score ≥ 15. COMISA patients had lower therapeutic HNS stimulation levels (1.5 V (COMISA) vs. 1.9 V, p < 0.01) and lower mean HNS stimulation level change from baseline (0.8 V (COMISA) vs. 1.01 V, p < 0.05) compared to non-COMISA patients. Fewer COMISA patients met Sher15 criteria (33.3% (n = 10) (COMISA) vs. 62.0% (n = 31), p = 0.02). When classifying COMISA and non-COMISA patients by post-operative HNS pathways, 60.0% (n = 18) of COMISA patients were within the Yellow Pathway Type 2 (adequate adherence, Sher15 nonresponse) compared to 32.0% (n = 16) of non-COMISA (p = 0.02), with no significant differences in rates within the other pathways. CONCLUSION: COMISA patients have lower therapeutic HNS stimulation levels, fewer stimulation level changes, and reduced rates of achieving Sher15 success criteria compared to those without COMISA. Managing expectations during stimulation uptitration and balancing implant stimulation tolerance and effectivness are required to optimize HNS outcomes.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Doan P, Durr ML, Chang JL, et al. Insomnia as a Clinical Predictor of Hypoglossal Nerve Stimulation Settings and Treatment Success. Laryngoscope. 2026. PMID: 42063279. doi:10.1002/lary.70587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。